Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Conference News VIVA 2019

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

L.A. McKeown

November 06, 2019

News Industry News

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

November 06, 2019

Presentation TCT 2019

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

Presenter: Edward Choke

September 28, 2019

Presentation TCT 2019

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Presenter: Aloke Finn

September 28, 2019

News Industry News

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

September 27, 2019

News Industry News

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

August 29, 2019

News Daily News

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

Caitlin E. Cox

August 15, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Conference News CRT 2019

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

L.A. McKeown

March 06, 2019

News Daily News

TCTMD’s Top 10 Most Popular Stories for February 2019

Shelley Wood

March 01, 2019

News Daily News

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

L.A. McKeown

February 20, 2019

News Daily News

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

L.A. McKeown

January 25, 2019

News Daily News

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

L.A. McKeown

January 23, 2019

Video

The Magic Touch - PTA Sirolimus Coated Balloon - Insights from pre-clinical evaluation

November 5, 2019

Video

XTOSI study: First In Man study of clinical use and safety of Sirolimus Coated PTA Balloon in the treatment of infrainguinal arterial disease

November 5, 2019

Partner Content

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

November 5, 2019

Advertisement

Hope for Bioresorbable Vascular Scaffolds in Peripheral Disease Below the Knee?

Intact Vascular Announces Positive Six-Month Data from TOBA II BTK Clinical Trial During Late-Breaking Session at 2019 VIVA Conference

XTOSI Study: First-in-Man Study of Clinical Use and Safety of Sirolimus-Coated PTA Balloon in the Treatment of Infrainguinal Arterial Disease

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Intact Vascular Announces Positive One-Year Data from TOBA III Clinical Trial

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

PET May Be Able to Pinpoint PAD Patients at Risk of Restenosis

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Acknowledgment of Safety Signal for Paclitaxel Devices in PAD May Mark Sea Change in Controversy

TCTMD’s Top 10 Most Popular Stories for February 2019

‘Inadvertent Reversal’ of Late Mortality Data Flips Advantage From Paclitaxel Zilver PTX Stent in PAD to PTA

IN.PACT Admiral Data Show No Death Difference at 5 Years for Paclitaxel DCBs vs PTA in Femoropopliteal Disease

Industry, Investigators Push Back With Patient-Level Data Showing No Increased Death From Paclitaxel-Based PAD Therapies

The Magic Touch - PTA Sirolimus Coated Balloon - Insights from pre-clinical evaluation

XTOSI study: First In Man study of clinical use and safety of Sirolimus Coated PTA Balloon in the treatment of infrainguinal arterial disease

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content